← All stories
Markets

GenIP Plc (GNIP) Announces H1 2026 Revenue of $53,641 and A3350,000 April Equity Placing Amid US Market Expansion

1 source ·1 article ·7h ago AIM ImmunoTech

GenIP Plc (AIM: GNIP, ticker reference: TEK), an AIM-listed provider specializing in AI-driven innovation intelligence and commercialisation services, has released its unaudited interim results for the six months ending 30 June 2026. The co…

Covered by 1 outlet

All coverage · 1 article